Funding for the study was obtained from Janssen Scientific Affairs, LLC. The authors thank Vikram Kilambi, B.S., B.A., Angelyn Fairchild, B.A., and Gail Zona, B.A., for their assistance at various stages of this project. The views expressed do not necessarily reflect those of Janssen Scientific Affairs, LLC.
Dr. Markowitz is an employee of UCB Biosciences, was formerly employed by Janssen Scientific Affairs, a Johnson & Johnson company, and owns stock in Johnson & Johnson, GlaxoSmithKline, and Pfizer. Dr. Levitan is an employee of Janssen Research and Development, Inc., a Johnson & Johnson company, and owns stock in Johnson & Johnson, Baxter International, Inc., Pharmaceutical HOLDRS Trust, and Zimmer Holdings, Inc. Ms. Mohamed is an employee of Bayer Healthcare Pharmaceuticals, Inc., and owns stock in Bayer. Dr. Alphs is an employee of Janssen Scientific Affairs, a Johnson & Johnson company, and owns stock in Johnson & Johnson. Dr. Citrome has engaged in collaborative research with or received consulting or speaking fees from Alexza Pharmaceuticals, Alkermes, AstraZeneca, Avanir Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Envivo, Forest Laboratories, Genentech, Janssen Pharmaceutical, Inc., Lundbeck, Merck, Mylan, Novartis, Noven, Otsuka, Pfizer, Reckitt Benckiser, Reviva Pharmaceuticals, Inc., Shire, Sunovion Pharmaceuticals, Inc., Takeda Pharmaceuticals, and Valeant Pharmaceuticals International. The other authors report no competing interests.